Zenith Clinical Research

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Obesity3 trials
• Familial hypercholesterolaemia2 trials
• Coronary artery disease1 trial
• Lung cancer1 trial
• Osteoarthritis1 trial
• Stroke1 trial

Phase

• Phase 34 trials

Status

• Active, not recruiting5 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Amgen1 trial
• Fractyl Health Inc.1 trial
• Guardant Health, Inc.1 trial
• Novo Nordisk A/S1 trial

Running trials

• Recruiting

  A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

  NCT07481630· Phase 3· Novo Nordisk A/S· Source

  Contact: Novo Nordisk

• Active, not recruiting

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· Phase 3· Amgen· Source

• Active, not recruiting

  Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide

  NCT06484114· Fractyl Health Inc.· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Screening for High Frequency Malignant Disease

  NCT05117840· Guardant Health, Inc.· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Obesity1 recruiting
• Osteoarthritis1 recruiting